Insulin Delivery Devices Market: Industry Analysis, Trend, Growth, Opportunity, Forecast 2022-2028 The Insulin Delivery Devices Market report research highlights key dynamics of the global sector. The potential of the industry has been investigated along with the key challenges. The current market scenario and prospects of the sector has also been studied. During the COVID-19 outbreak, restraints on movement through lockdowns and high expenses posed major threats to the market growth, however, support by government authorities to clinically practice teleconsultation has aided in balancing the market expansion. Browse key industry insights spread across 130 pages with 280 market data tables & 14 figures & charts from the report, “Insulin Delivery Devices Market Analysis By Product (Insulin Pumps {Tubed/Tethered Pumps, Tubeless Pumps}, Insulin Pens {Reusable, Disposable}, Insulin Pen Needles {Standard, Safety}, Insulin Jet Injectors, Insulin Syringes), End-use (Home Care, Hospitals & Clinics), Industry Analysis Report, Regional Outlook , Application Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/insulin-delivery-devices-market For instance, in March 2022, the U.S. House of Representatives passed a bill to implement the Affordable Insulin Now Act by 2023 that would reduce cost-allocation for insulin under private and public health insurance and Medicare. The act is expected to lower the cost of insurance negotiated price by around 25% which is likely to propel the market demand. Major market players have been focusing on research and introducing innovative products to acquire maximum business revenue. For instance, in April 2022, Ypsomed Holding, a leading technology-based insulin devices manufacturer, partnered with Abbott and CamDiab, renowned healthcare companies, to develop and commercialize an integrated automated insulin delivery (AID) system. The AID system will connect Abbott's Freestyle Sensor to CamDiab's mobile app via Ypsomed Mylife Ypso pump to monitor glucose levels in a diabetic patient on a minute reading basis. To cite another instance, in April 2022, Tandem Diabetes Care, another major player in the industry, announced positive results from its newly released t: slim X2 insulin pump that creates immediate and constant improvements in glycemic control showcasing a reduced burden of diabetic management. The insulin delivery devices market has been bifurcated based on end-use, product, and region. The product segment has been further divided into insulin pumps, insulin jet injectors, insulin pens, insulin syringes, insulin pen needles, and others.
© 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com